Category: 2018-1
2017
PopularContaining antimicrobial resistance is a smart investment in global public health and wealth
Dr Eni̇s Bariş, Practice Manager, Health, Nutrition and Population Global Practice, World Bank; Alexander Irwin, Consultant, Health, Nutrition and Population Global Practice, World Bank; Alessia Thiebaud, Research Analyst,...
Economics and Innovation
LatestThe Economics of reducing antibiotic use to reduce antimicrobial resistance
Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...
2017
Healthcare
PopularImproving rational antibiotic treatment of common childhood conditions in Uganda
Dr Tamar Chitashvili, Md, Senior Improvement Advisor, University Research Co., Llc, Uganda; Dr Ekaterine Cherkezishvili, Md, Mph, Research Consultant, University Research Co., Llc, Uganda; Dr Esther Karamagi, Md, Mbchb, Msc,...
Economics and Innovation
Top RatedThe Economics of reducing antibiotic use to reduce antimicrobial resistance
Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...
All
Latest
Phage therapy: A promising weapon in the global superbug crisis
Phage therapy: A promising weapon in the global superbug crisis Dr Steffanie Strathdee, Associate Dean of Global Health Sciences, Harold Simon Professor of Medicine and Co-Director, Center for Innovative Phage Applications
- All
- Diagnostics
- Rational use of antibiotics
Phage therapy: A promising weapon in the global superbug crisis
Phage therapy: A promising weapon in the global superbug crisis Dr Steffanie Strathdee, Associate Dean of Global Health Sciences, Harold Simon Professor of Medicine and Co-Director, Center for Innovative Phage Applications
Augmented* medicine for all
Fabienne Ostermeyer, International Development Director, Visiomed Group International Imagine if...
The evolution of the global antibiotic resistance partnership
Hellen Gelband, Associate Director for Policy, Center for Disease Dynamics, Economics & Policy...
Global Health Dynamics
Cancer Control
